ArticleBiological trace element research2026
Effects of Dietary Nano-Selenium on Growth, Selenoprotein Gene Expression, and Antioxidant Adaptation in Pot-Bellied Seahorse (Hippocampus abdominalis).
Article in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe pot-bellied seahorse (Hippocampus abdominalis) is a high-value marine teleost, but its responses to dietary selenium (Se) remain poorly characterized.
methodsThis 70-day trial evaluated nominal nano-selenium (Nano-Se) supplementation levels of 0, 10, 20, and 40 mg/kg; the unsupplemented frozen mysis shrimp contained 0.97 mg Se/kg on a wet-weight basis.
resultsCompared with the control, body weight gain and specific growth rate were higher, and feed conversion ratio was lower at 20 and 40 mg/kg. Additionally, body length gain was increased at 10 and 40 mg/kg. Tissue Se concentrations increased with supplementation and were highest in the liver. Nano-Se increased intestinal villus height and digestive enzyme activities; no overt histopathological lesions were observed in the examined sections. Intestinal 16S rRNA gene sequencing identified changes in microbial diversity and taxonomic composition. Untargeted lipidomics identified semi-quantitative changes in hepatic triglyceride-, phospholipid-, and ether-lipid-associated ion signals. Hepatic superoxide dismutase, catalase, and glutathione peroxidase activities were lower in supplemented groups than in the control. Catalase and superoxide dismutase activities were higher at 40 than at 20 mg/kg, whereas glutathione peroxidase did not differ between doses. Steady-state messenger RNA abundances of selenoprotein-related genes and whole-body sex steroid concentrations also changed.
conclusionsOverall, Nano-Se elicited dose- and endpoint-dependent responses, with no single dose consistently superior. The 10-20 mg/kg range warrants further evaluation, whereas 40 mg/kg maximized Se accumulation. These findings provide a basis for refining Nano-Se dose selection in seahorse aquaculture, although the optimal inclusion level and upper safe limit remain unresolved.
Indexed as
Identifiers
42823598What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.